Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03690011 |
|
Recruitment Status :
Recruiting
First Posted : October 1, 2018
Last Update Posted : April 12, 2024
|
Sponsor:
Baylor College of Medicine
Collaborators:
The Methodist Hospital Research Institute
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
LaQuisa Hill, Baylor College of Medicine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 1, 2025 |
| Estimated Study Completion Date : | May 1, 2040 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):